CHE
Chemed Corporation
NYSE · Healthcare · Medical - Care Facilities · US
$522.75
−0.32%Sep 3, 2026, 20:01 UTC
Scott+Scott Attorneys at Law LLP launched an investigation into Chemed Corporation's officers and directors for potential breach of fiduciary duties related to alleged Medicare overbilling.
Source:Aug 20, 2026, 07:13 UTC
Abacus FCF Advisors LLC acquired a new stake of 8,239 shares in Chemed Corporation during the second quarter, valued at approximately $3,837,000, as disclosed in an SEC filing.
Source:Aug 6, 2026, 15:57 UTC
Chemed Corporation's Board of Directors declared a quarterly cash dividend of 70 cents per share, payable on September 3, 2026, to shareholders of record as of August 17, 2026.
Source:Aug 5, 2026, 10:39 UTC
Activist pressure is pushing Chemed Corporation to consider a spin-off of its VITAS segment to unlock value, as reported on August 5, 2026.
Source:Jul 28, 2026, 20:15 UTC
Chemed Corporation reported financial results for the second quarter ended June 30, 2026, with consolidated revenue increasing 8.8% to $673.3 million and GAAP diluted EPS rising 43.7% to $5.13.
Jun 8, 2026, 19:15 UTC
Roto-Rooter Services Company, a subsidiary of Chemed Corporation, acquired a formerly independent Roto-Rooter franchise serving 21 counties in south Texas for approximately $12.0 million.
Source: